¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Sulfasalazine Delayed-Release Tablets"¿¡ ´ëÇÑ ¿µ¿µ ÀÇÇлçÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
sulfasalazine <chemical> A drug that is used in the management of inflammatory bowel diseases, its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (mesalazine) released in the colon. It is also used in the treatment of severe or progressive rheumatoid arthritis not responding to analgesics or anti-inflammatory drugs.
Pharmacological action: anti-infective agents, anti-inflammatory agents, antirheumatic agents, gastrointestinal agents.
Chemical name: Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-
(12 Dec 1998)
tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form.
(12 Dec 1998)
tablets, enteric-coated Tablets coated with material that delays release of the medication until after they leave the stomach.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á